AAAAAA

   
Results: 1-7 |
Results: 7
CALCULATED AND EXPERIMENTAL LOW-ENERGY CONFORMATIONS OF CYCLIC UREA HIV PROTEASE INHIBITORS
Authors: HODGE CN LAM PYS EYERMANN CJ JADHAV PK RU Y FERNANDEZ CH DELUCCA GV CHANG CH KALTENBACH RF HOLLER ER WOERNER F DANEKER WF EMMETT G CALABRESE JC ALDRICH PE
Citation: Cn. Hodge et al., CALCULATED AND EXPERIMENTAL LOW-ENERGY CONFORMATIONS OF CYCLIC UREA HIV PROTEASE INHIBITORS, Journal of the American Chemical Society, 120(19), 1998, pp. 4570-4581
DESIGN, SYNTHESIS, AND EVALUATION OF TETRAHYDROPYRIMIDINONES AS AN EXAMPLE OF A GENERAL-APPROACH TO NONPEPTIDE HIV PROTEASE INHIBITORS
Authors: DELUCCA GV LIANG J ALDRICH PE CALABRESE J CORDOVA B KLABE RM RAYNER MM CHANG CH
Citation: Gv. Delucca et al., DESIGN, SYNTHESIS, AND EVALUATION OF TETRAHYDROPYRIMIDINONES AS AN EXAMPLE OF A GENERAL-APPROACH TO NONPEPTIDE HIV PROTEASE INHIBITORS, Journal of medicinal chemistry, 40(11), 1997, pp. 1707-1719
IMPROVED CYCLIC UREA INHIBITORS OF THE HIV-I PROTEASE - SYNTHESIS, POTENCY, RESISTANCE PROFILE, HUMAN PHARMACOKINETICS AND X-RAY CRYSTAL-STRUCTURE OF DMP-450
Authors: HODGE CN ALDRICH PE BACHELER LT CHANG CH EYERMANN CJ GARBER S GRUBB M JACKSON DA JADHAV PK KORANT B LAM PYS MAURIN MB MEEK JL OTTO MJ RAYNER MM REID C SHARPE TR SHUM L WINSLOW DL ERICKSONVIITANEN S
Citation: Cn. Hodge et al., IMPROVED CYCLIC UREA INHIBITORS OF THE HIV-I PROTEASE - SYNTHESIS, POTENCY, RESISTANCE PROFILE, HUMAN PHARMACOKINETICS AND X-RAY CRYSTAL-STRUCTURE OF DMP-450, Chemistry & biology, 3(4), 1996, pp. 301-314
CYCLIC HIV PROTEASE INHIBITORS - SYNTHESIS, CONFORMATIONAL-ANALYSIS, P2 P2' STRUCTURE-ACTIVITY RELATIONSHIP, AND MOLECULAR RECOGNITION OF CYCLIC UREAS/
Authors: LAM PYS RU Y JADHAV PK ALDRICH PE DELUCCA GV EYERMANN CJ CHANG CH EMMETT G HOLLER ER DANEKER WF LI LZ CONFALONE PN MCHUGH RJ HAN Q LI RH MARKWALDER JA SEITZ SP SHARPE TR BACHELER LT RAYNER MM KLABE RM SHUM LY WINSLOW DL KORNHAUSER DM JACKSON DA ERICKSONVIITANEN S HODGE CN
Citation: Pys. Lam et al., CYCLIC HIV PROTEASE INHIBITORS - SYNTHESIS, CONFORMATIONAL-ANALYSIS, P2 P2' STRUCTURE-ACTIVITY RELATIONSHIP, AND MOLECULAR RECOGNITION OF CYCLIC UREAS/, Journal of medicinal chemistry, 39(18), 1996, pp. 3514-3525
STUDIES ON ORALLY AVAILABLE INHIBITORS OF HIV PROTEASE - PEPTIDYL ALDEHYDES AND TRIFLUOROMETHYL KETONES
Authors: HODGE CN ALDRICH PE FERNANDEZ CH OTTO MJ RAYNER MM WONG YN ERICKSONVIITANEN S
Citation: Cn. Hodge et al., STUDIES ON ORALLY AVAILABLE INHIBITORS OF HIV PROTEASE - PEPTIDYL ALDEHYDES AND TRIFLUOROMETHYL KETONES, Antiviral chemistry & chemotherapy, 5(4), 1994, pp. 257-262
DMP-323, A NONPEPTIDE CYCLIC UREA INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEASE, SPECIFICALLY AND PERSISTENTLY BLOCKS INTRACELLULAR PROCESSING OF HIV GAG POLYPROTEIN
Authors: RAYNER MM CORDOVA BC MEADE RP ALDRICH PE JADHAV PK RU Y LAM PYS
Citation: Mm. Rayner et al., DMP-323, A NONPEPTIDE CYCLIC UREA INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEASE, SPECIFICALLY AND PERSISTENTLY BLOCKS INTRACELLULAR PROCESSING OF HIV GAG POLYPROTEIN, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1635-1640
PHARMACOLOGY OF ]BUTYLSULFINYL)PHENYL)-6-METHYL-5-NITRO-3-PYRIDINE CARBOXYLIC-ACID METHYL-ESTER (XB513), A NOVEL CALCIUM AGONIST WITH ALPHA-1-ADRENERGIC RECEPTOR ANTAGONISTIC PROPERTY
Authors: WONG PC ALDRICH PE CHIU AT EARL RA HART SD JOHNSON AL MA P MCCALL DE PRICE WA SMITH RD WEXLER RR TIMMERMANS PBMWM
Citation: Pc. Wong et al., PHARMACOLOGY OF ]BUTYLSULFINYL)PHENYL)-6-METHYL-5-NITRO-3-PYRIDINE CARBOXYLIC-ACID METHYL-ESTER (XB513), A NOVEL CALCIUM AGONIST WITH ALPHA-1-ADRENERGIC RECEPTOR ANTAGONISTIC PROPERTY, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1088-1095
Risultati: 1-7 |